Interactions between gold nanoparticles and amyloid β25-35 peptide

Area of Science:

• Biochemistry
• Nanotechnology
• Neuroscience

Background:

• Alzheimer's disease is characterized by the aggregation of amyloid-beta (Aβ) peptides.
• The Aβ25-35 peptide fragment exhibits rapid aggregation and significant neurotoxicity.
• Understanding Aβ interactions is crucial for developing diagnostic and therapeutic strategies.

Purpose of the Study:

• To investigate the interactions between gold nanoparticles (GNPs) and Aβ25-35 peptide.
• To explore how varying conditions (molar ratio, temperature, pH) affect these interactions.
• To assess the potential of GNP-Aβ25-35 interactions as a diagnostic marker for Alzheimer's disease.

Main Methods:

• Utilized ultraviolet-visible and circular dichroism spectroscopy.
• Employed thioflavin T fluorescence assays.
• Conducted transmission electron microscopy (TEM) for structural analysis.

Main Results:

• Aβ25-35 monomers and oligomers induced GNP aggregation at specific concentrations.
• Higher concentrations of Aβ25-35 led to the dissociation of GNP aggregates.
• Increased temperature and lower pH accelerated the aggregation rate.

Conclusions:

• GNP-Aβ25-35 interactions are concentration-dependent and sensitive to environmental factors.
• The observed aggregation and dissociation phenomena offer a potential basis for Alzheimer's disease detection.
• Further development could lead to a novel, simple diagnostic tool for Alzheimer's disease.